Back to CYTR Stock Lookup

CytRx (CYTR) – Press Releases

Jan 22, 2015 09:00 AM CytRx Announces Overall Survival Results from Its Global Phase 2b Clinical Trial of Aldoxorubicin in Soft Tissue Sarcoma
Jan 20, 2015 06:00 AM CytRx Announces FDA's Removal of Partial Clinical Hold for Aldoxorubicin Clinical Trials Permitting Immediate Enrollment of New Patients
Jan 8, 2015 09:00 AM CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results as a Treatment for HIV-Related Kaposi's Sarcoma (KS)
Jan 6, 2015 06:00 AM CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results in Glioblastoma Multiforme (Brain Cancer)
Dec 3, 2014 06:00 AM CytRx Receives Written FDA Communication Regarding Partial Clinical Hold for Aldoxorubicin Clinical Trials
Dec 2, 2014 06:00 AM CytRx to Present at the Oppenheimer 25th Annual Healthcare Conference
Nov 18, 2014 06:00 AM CytRx Announces Partial Clinical Hold Affecting Aldoxorubicin Clinical Trials
Nov 4, 2014 06:00 AM CytRx Reports 2014 Third Quarter Financial Results

Back to CYTR Stock Lookup